Izafe Group AB logo

Izafe Group AB (M02)

Market Closed
5 Dec, 20:00
XSTU XSTU
0. 04
-0
-8.61%
5M Market Cap
- P/E Ratio
0% Div Yield
0 Volume
- Eps
0.05
Previous Close
Day Range
0.04 0.04
Year Range
0.01 0.07
Want to track M02 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

M02 closed Friday lower at €0.04, a decrease of 8.61% from Thursday's close, completing a monthly decrease of -12.89% or €0.01. Over the past 12 months, M02 stock gained 374.47%.
M02 is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on XSTU (EUR).

M02 Chart

Similar

06H
BPC Instruments AB
-
-
Z4U
Realpha Technologies Corp.
-
-
8FE
Forever Entertainment S.A.
0.53
-5.32%
8J9
Tap Global Group PLC
0.02
+28.57%
0YG
Ultimate Games S.A.
2.77
+2.97%

Izafe Group AB (M02) FAQ

What is the stock price today?

The current price is €0.04.

On which exchange is it traded?

Izafe Group AB is listed on XSTU.

What is its stock symbol?

The ticker symbol is M02.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, the market cap is 5M.

Has Izafe Group AB ever had a stock split?

No, there has never been a stock split.

Izafe Group AB Profile

Electronic Equipment, Instruments & Components Industry
Information Technology Sector
- CEO
XSTU Exchange
- ISIN
Sweden Country
7 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

iZafe Group AB (publ) is a pioneering life-science company specialized in the research, development, and marketing of digital medical solutions and services aimed at enhancing drug management safety for individuals at home. Originally established as MediRätt AB (publ), the company underwent a name change to iZafe Group AB (publ) in May 2019, signaling its evolution and broadened ambition within the digital healthcare sector. Since its inception in 2008, iZafe Group has been committed to addressing the challenges of medication management through innovative technologies. Based in Stockholm, Sweden, the company extends its reach to consumers and care providers across Sweden, the Nordic countries, and the international market, catering to both the public and private sectors.

Products and Services

  • Dosell - an automated drug dispenser designed to simplify and secure the process of medication intake for individuals. The device is equipped to handle dose bags, facilitating easier and more independent medication management for users. Dosell ensures that medications are taken at the correct times by providing reminders and alerts for missed doses. This product highlights iZafe Group's commitment to leveraging technology to improve health outcomes and support independent living.

Contact Information

Address: David Bagares Gata 3
Phone: 46 8 21 11 21